Their conclusion echoes what others have found when they've looked at the body of evidence for these therapies
Noteworthy, these were recently combined with the mentioned evidence that BPC 157 therapy by rapidly activated collateral pathways (azygos vein direct blood flow delivery) goes as a particular therapy effect, as counteracted the vascular and multiorgan failure concomitant to various major vessel occlusion and similar various noxious procedures and various agents application [40,41,42,43,47,48,49,50,51,52,53,54,55,56]
A., & Fisher, G
As of the date and present studies circulating, BPC 157 has few to no side effects
This statement, published in the peer-reviewed Journal of Endocrinology and Metabolism, represents the consensus finding across all six trials and nearly 900 participants
Any researcher who purchased products from Paradigm Peptides should verify those products through independent testing before use